Status:
COMPLETED
The Effect of Sujok Therapy on Cancer Symptoms
Lead Sponsor:
Ataturk University
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to determine the effect of Sujok therapy on Pain, Fatigue, Insomnia, Nausea and Vomiting experienced by patients with gastrointestinal system cancer.
Detailed Description
The aim of this study is to determine the effect of Sujok treatment on Pain, Fatigue, Insomnia, Nausea and Vomiting experienced by patients with gastrointestinal system cancer. Intervention and contro...
Eligibility Criteria
Inclusion
- over 18 years old
- Fatigue Severity Measurement - Visual Analogue Scale (VAS) fatigue score of 3 and above,
- Pain Severity Measurement - Visual Analogue Scale (VAS) pain score of 3 and above,
- Measurement of Nausea and Vomiting Severity - Patients with a Visual Analogue Scale (VAS) nausea and vomiting score of 3 and above will be included.
Exclusion
- Loss of sensation, amputation, injury, colostomy, etc., which will prevent practice in hands. patients will be excluded from the study.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 5 2022
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT05265754
Start Date
February 1 2022
End Date
September 5 2022
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atatürk Universty
Erzurum, Turkey (Türkiye)